Institut Paoli-Calmettes: Pancreatic Neoplasms trials
The registry lists 16 Pancreatic Neoplasms studies with Institut Paoli-Calmettes as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 1 1Phase 3 2No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Predicting Pancreatic Fistula After Pancreatic Surgery Using Preoperative ImmunityNot yet recruitingNCT07827911
- Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma PatientsRecruitingNCT06046794Not applicable
- Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the PancreasNot yet recruitingNCT06000553Not applicable
- Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell LevelRecruitingNCT04677244Not applicable
- Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine TumorsRecruitingNCT04520932Not applicable
- Pancreatic Surgical DatabaseRecruitingNCT02871336
- Institut Paoli-Calmettes Pancreatic Neoplasms DatabaseRecruitingNCT02869581
- A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
- The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic FistulaCompletedNCT04724551
- Evolution of Body Connection After SurgeryCompletedNCT04422730
- Evaluation of the Impact of Pancreatectomy on Systemic ImmunityStatus unknownNCT03978702Not applicable
- Onco-geriatric Database of Patients With Pancreatic CancerStatus unknownNCT02858141
- Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic TumorsCompletedNCT01692873Not applicable
- NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic CancerCompletedNCT01521702Phase 3
- Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct TumorCompletedNCT00930410Not applicable
- Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00541021Phase 3